Get Started
Breast Cancer Curricula
Step 1



The Advanced Certificate Program in
Breast Cancer Management III
  1. Curriculum III
  2. Curriculum II
  3. Curriculum I
  4. Full Course List
Search by


Currently Available

Course Title Curriculum Faculty Release Date
Expert Insight Into: Anti-VEGF Monoclonal Antibody Plus Taxane-based Chemotherapy for Locally Recurrent or Metastatic Breast Cancer (Part 10 of Series)Article Review (BC03.13) 1981.10 III Esteva Dec 2010
Expert Insight Into: Longer Therapy, Amenorrhea, and Breast Cancer (Part 9 of Series)Article Review (BC03.11) 1981.09 III Burstein Nov 2010
Expert Insight Into: Prognostic and Predictive Value of a Multigene Tumor Assay in Postmenopausal Women with Node-Positive, Estrogen-Receptor–Positive Breast Cancer on Chemotherapy (Part 8 of Series) Article Review (BC03.10) 1981.08 III Carey Nov 2010
Case Study: Hormone Receptor-Positive, HER2-Positive Metastatic Breast Cancer with Multiple MetastasesTx Reporter e-Newsletter (BC03.12) 1982.02 III Burstein
Carey
Nov 2010
Expert Insight Into: Open Label, Phase II Trial of an Irreversible ErbB Receptor Tyrosine Kinase Inhibitor in Patients with Advanced ErbB2-Positive Breast Cancer (Part 7 of Series)Article Review (BC03.09) 1981.07 III Burstein Oct 2010
Breast Cancer Tumor Board PodcastPodcast Series (BC03.08) 1983 III Burstein
Golshan
Bellon
Sep 2010
Expert Insight Into: Selective Serotonin Reuptake Inhibitors and Breast Cancer Mortality in Women Receiving a Selective Estrogen Receptor Modulator (Part 6 of Series)Article Review (BC03.07) 1981.06 III Carey Sep 2010
Expert Insight Into: The Combination of Two Anti-HER2 Monoclonal Antibodies in Patients with HER2-Positive Metastatic Breast Cancer that Progressed During Prior Therapy with One of These Agents. (Part 5 of Series)Article Review (BC03.06) 1981.05 III Esteva Aug 2010
Expert Insight Into: Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving VEGF Inhibitors. (Part 4 of Series)Article Review (BC03.05) 1981.04 III Burstein Aug 2010
Expert Insight Into: Aspirin Intake and Survival After Breast Cancer (Part 3 of Series) Article Review (BC03.03) 1981.03 III Carey Jul 2010
Case Study: Refractory HER2-Positive Metastatic Breast CancerTx Reporter e-Newsletter (BC03.04) 1982.01 III Burstein
Esteva
Jul 2010
Expert Insight Into: Recurrence Score for Distant Recurrence Risk in Node-Negative/Node-Positive Postmenopausal Breast Cancer Patients Receiving Hormone Therapy (Part 2 of Series)Article Review (BC03.02) 1981.02 III Burstein Jun 2010
Expert Insight Into: Prevention of Aromatase Inhibitor-Induced Bone Loss Using a Bisphosphonate: The SABRE Trial (Part 1 of Series)Article Review (BC03.01) 1981.01 III Burstein Jun 2010